Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +574,432 574,432
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +1,876,624 1,876,624
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +251,211 251,211
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +997,433 997,433
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +340,712 340,712
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +2,225,316 2,225,316
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion +359,374 359,374
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −522,355 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −1,706,490 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −228,438 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −907,007 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −309,823 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −2,023,568 0
2021-08-03 Fletcher Aaron G.L. 10% owner Conversion · Series A Preferred Stock −326,795 0
2021-08-03 FAIRBAIRN EMILY Director Conversion +83,124 91,336
2021-08-03 FAIRBAIRN EMILY Director Conversion +27,706 27,706
2021-08-03 FAIRBAIRN EMILY Director Conversion +3,222,485 3,222,485
2021-08-03 FAIRBAIRN EMILY Director Purchase +100,000 $10.00 $1.0M 3,322,485
2021-08-03 FAIRBAIRN EMILY Director Conversion · Series A Preferred Stock −75,588 0
2021-08-03 FAIRBAIRN EMILY Director Conversion · Series A Preferred Stock −25,195 0

Page 15 of 16 · 309 trades